Starling Oncology Operating Margin Growth & History (STLN)

Starling Oncology's operating margin was −7.18% for fiscal 2025.

View full Starling Oncology company overview

Starling Oncology annual operating margin history

Starling Oncology annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−7.18%+8.10 pp
20242024-12-31−15.28%+8.47 pp
20232023-12-31−23.75%+8.70 pp
20222022-12-31−32.46%−9.87 pp
20212021-12-31−22.59%−18.22 pp
20202020-12-31−4.37%

Starling Oncology operating margin trends

Over the last five reported fiscal years, Starling Oncology's operating margin decreased from −4.37% to −7.18%, a change of −2.81 percentage points. The latest reported quarter, Q2 2026, shows −2.86%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Starling Oncology filings at SEC.gov ↗